• Profile
Close

Daily oral administration of the novel androgen 11β-MNTDC markedly suppresses serum gonadotropins in healthy men

Journal of Clinical Endocrinology & Metabolism Mar 10, 2020

Yuen F, Thirumalai A, Pham C, et al. - Given that 11β-methyl-19-nortestosterone (11β-MNT) is a modified testosterone (T) with androgenic and progestational activity, researchers conducted a randomized, double-blind study at two academic medical centers to test the safety and tolerability of daily oral 11β-MNT dodecylcarbonate (11β-MNTDC) in healthy men. Forty-two healthy men, aged 18 to 50 years, were randomized to receive oral placebo or 11β-MNTDC, 200 or 400 mg daily, for 28 consecutive days. In healthy men, daily oral 11β-MNTDC for 28 days markedly suppressed serum gonadotropin and T concentrations without serious adverse effects. Such findings require further review of the 11β-MNTDC as a potential male oral contraceptive.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay